EIX made it to the Zacks Rank #1 (Strong Buy) value stock list on October 29, 2025.

GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs.

Achieved commercially viable yield for IM1240, positioning the program competitively for future development Validates scalability of the CAPTN-3 tri-specific antibody platform IM1240, the first CAPTN-3 tri-specific antibody targeting the novel tumor-associated antigen 5T4, advances toward first-in-human clinical trials, with an Investigational New Drug (IND) submission planned for 2026 REHOVOT, Israel, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced the achievement of a manufacturing milestone for IM1240, a tri-specific antibody from the CAPTN-3 platform, which …

Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.

Clover's latest star rating downgrade was mainly driven by low member experience scores, which is an aspect it fully controls in its business. Despite low member experience scores, members' ratings for CLOV's health plan increased YoY, and fewer members are expected to leave its plan, which could offset new members' higher medical costs. The company's SaaS inflection point could be nearing through a potential partnership with Humana, which appears to be deploying Counterpart Assistant into its digital infrastructure.

FLG reports a Q3 loss as declines in net interest and fee income outweigh cost reductions and stronger capital.

AMITYVILLE, N.Y. , Oct. 29, 2025 /PRNewswire/ -- NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading designers and manufacturers of high-tech electronic security devices, wireless recurring communication services for intrusion, fire alarm, access control and locking systems as well as a leading provider of school safety solutions will release financial results for its Fiscal First Quarter 2026, which ended September 30, 2025, on Monday November 3, 2025 before the market open followed by a conference call for analysts and investors at 11 A.M.

FORT LAUDERDALE, Fla. , Oct. 29, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets under management, released a follow-up presentation to the Board of Directors of Columbia Banking System, Inc., attaching a copy of the presentation previously provided to the Board of Directors on September 14, 2025 entitled "Failed Gambles Borne Solely By Owners – Protective Covenants Needed.

Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) lesions over lifetime PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 29, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce a strategic collaboration with the Gorlin Syndrome Alliance (GSA) to advance compassionate access to SKINJECT™, the Company's investigational doxorubicin containing microneedle arrays (D-MNA) for patients suffering from …

Further Recoveries Anticipated Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) (the "Company") announced today that the Company has received $4.4 million in recovered funds from the Canada Revenue Agency ("CRA") as a result of the Supreme Court of BC ("SCBC") reversing CRA's previous decision to deny BC Mineral Exploration Tax Credits ("BC METC") for the years 2010 and 2011. Seabridge had already received reimbursement of trial costs and has now fully recovered the funds which CRA held during the appeal process and accrued interest.

ARLINGTON, Va., Oct. 29, 2025 /PRNewswire/ -- Third Quarter 2025 737 stabilized production at 38 per month; jointly agreed with FAA in October to increase to 42 per month Revenue increased to $23.3 billion primarily reflecting 160 commercial deliveries Earnings reflects impact of $4.9 billion charge associated with updated 777X certification timing Operating cash flow of $1.1 billion and free cash flow (non-GAAP)* of $0.2 billion Total company backlog grew to $636 billion, including over 5,900 commercial airplanes Table 1.

The intersection of Blue Gold's strategy with global adoption of blockchain technology and responsible regulation, a renewed focus on gold as a store of value, and a growing demand for real assets as credible alternatives to fiat currencies The intersection of Blue Gold's strategy with global adoption of blockchain technology and responsible regulation, a renewed focus on gold as a store of value, and a growing demand for real assets as credible alternatives to fiat currencies

WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in three upcoming healthcare conferences in November. On Wednesday November 12, 2025, at 11:00 AM EST, Aclaris' Chief Executive Officer Dr. Neal Walker and other members of Aclaris' senior leadership team will participate in a fireside chat during the Guggenheim 2nd Annual Healthcare Conference in Boston, MA.

BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025.

LOUISVILLE, Ky., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today reported record earnings of $36.2 million, or $1.23 per diluted share, for the third quarter ended September 30, 2025.

Appoints new leader of Americas & Asia Pacific; Simplifies management structure; Strengthens Execution GREENWICH, Conn., Oct. 29, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world's largest pure-play contract logistics provider, today announced organizational changes to accelerate growth, simplify its structure, and strengthen execution.

ADAS-Cog13 difference −12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144

Strong Balance Sheet and Market-Leading Technologies Enable Continued Investments in Growth Strong Balance Sheet and Market-Leading Technologies Enable Continued Investments in Growth

CELEBRATION, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra's executive leadership team will participate in a fireside discussion at Guggenheim's 2nd Annual Healthcare Innovation Conference in Boston, MA on Wednesday, November 12, 2025, at 11:30 a.m. ET.

ARLINGTON, Va.--(BUSINESS WIRE)--Leonardo DRS, Inc. (Nasdaq: DRS), a leading provider of advanced defense technologies, today reported financial results for the third quarter 2025, which ended September 30, 2025. CEO Commentary “Broad-based customer demand was evident in our exceptional bookings and organic revenue growth in the third quarter. Our year-to-date performance puts us on a solid path to deliver double-digit revenue growth and to execute against our financial commitments for 2025. We.